Specialist in Clinical Neurology and Preventive Medicine & Public Health, Jesús de Pedro Cuesta holds Spanish and Swedish citizenship and a Spanish and Swedish board-certificates in neurology. He was formally trained at the Karolinska Institute in social medicine and obtained a PhD degree in Health Services Research in 1986. For 1986-2005, he headed the Neuroepidemiology Unit at Huddinge University Hospital (Division of Neurology, Karolinska Institute). From 1994 to 2009 he was responsible for the Spanish National CJD Register. Major interest fields are epidemiology and services research on neurodegenerations including prion disorders and neuro-autoimmune diseases. Present position, since 1991: Head of the Department of Applied Epidemiology at the National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain. He has published approximately 150 epidemiological and health-services research papers in international peer-reviewed journals.

Scientific publications

  1. Gunnarsson LG, Lygner PE, de Pedro-Cuesta J, Veiga-Cabo J. An epidemic-like cluster of motor neuron disease in the County of Skaraborg, Sweden, 1973-1984. Neuroepidemiology 1996:15:142-152
  2. de Pedro-Cuesta J, Petersen IJ, Stawiarz L, Gudmundsson G, Gudmundsson G, Almazán J, Tulinius H, Johansson H. High levodopa use in periodically, time-clustered, Icelandic birth cohorts. A vestige of Parkinsonism etiology?. Acta Neurol Scand 1995:91:79-88
  3. de Pedro-Cuesta J, Gudmundssson G, Abraira V, Gudmundsson G, Almazán J, Veiga J, Tulinius H, Löve A. Whooping cough and Parkinson´s Disease. Int J Epidemiology. 1996:25:1301-1311
  4. I Zerr, M. Pocchiari, S Collins, JP Brandel, J. de Pedro Cuesta, RSG Knight, Bernheimer H, Cardone F, Delasnerie-Laupretre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremon A, Budka H, LaplancheJL, Will RG, Poser S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-5.
  5. Jin YP, de Pedro-Cuesta J, Söderström M. Predicting Multiple Sclerosis at Optic Neuritis Onset. Multiple Sclerosis 2003; 9: 135-141
  6. A Ladogana, M Puopolo, E Croes, H Budka, C Jarius, S Collins, C Masters, T Sutcliffe, A Guilivi, A Alperovitch, N Delasniere-Laupretre, J-P Brandel, S Poser, H Kretschmar, E Mitrova, J de Pedro Cuesta, P. Martinez-Martín, M Glatzel, A Aguzzi, R Knight, H Ward, M Pocchiari, C van Duijn, RG Will, I Zerr . Descriptive Epidemiology of Creutzfeldt-Jakob disease 1993-2000): The EUROCJD Collaborative study. Neurology 2005,65:1586-9129.
  7. de Pedro-Cuesta J, Bleda MJ, Rabano A, Cruz M, Laursen H, Molbak K, Siden A; on behalf of the EUROSURGYCJD Research Group. Classification of surgical procedures for epidemiologic assessment of sporadic Creutzfeldt-Jakob Disease transmission by surgery. Eur J Epidemiol. 2006;21:595-604.
  8. de Pedro-Cuesta J, Markus GlatzeL M, Almazan J, Stoeck K, Mellina V, Puopolo M, Pocchiari M, Zerr I, Kretzschmar HA, Brandel JP, Delasnerie-Laupretre N, Alperovitch A, van Duijn C, Sanchez-Juan P, Collins S, Lewis V, Jansen GH, Coulthart MB, Gelpi E, Budka H and Mitrova E. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. BMC Public Health 2006,
  9. Mahillo-Fernandez I, De Pedro Cuesta J, Bleda MJ, Cruz M, Mølbak K, Laursen H, Falkenhorst G, Martínez-Martín P, Siden Å. Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology, 2008, 2008; 31:229-40